Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. UPLOAD Other SEC-generated Letter
  3. S-3 Offering Registration Statement
  4. POS AM Other Post-effective Amendment for Registration Statement
  5. 424B3 Offering Prospectus
  6. DEF 14A Proxy Proxy Statement
  7. PRE 14A Proxy Proxy Statement (Preliminary)
  8. 8-K/A Event Exhibits
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 424B3 Offering Prospectus
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 8-K Event Regulation FD disclosure
  18. 424B3 Offering Prospectus
  19. 8-K Event Executive or director change
  20. 4/A Insider Changes in Ownership

Page 35 of 41 · 809 filings